Information About the Totect Emergency Kit Patent

REIMBURSEMENT INFORMATION

6 year replacement Kit Policy

DETECT
Anthracycline extravasation

TOTECT^®
How it works

HELP PROTECT
Your patients from tissue damage

CONTACT

MEDICAL SUPPORT HOTLINE

PACKAGE INSERT

PUBLICATIONS and PRESENTATIONS

TOTECT^® TOOLS

PUBLICATIONS

"TOTECT^®: A New Agent for Treating Anthracycline Extravasation."  Lisa Schulmeister, RN, MN, APRN-BC, OCN^®, FAAN.  Clinical Journal of Oncology Nursing (CJON), June 2007, (Vol. 11, No. 3).  This article appears on this site with the permission of the Oncology Nursing Society.
http://www.ons.org/publications/journals/CJON/Volume11/Issue3/pdf/1103387.pdf
 

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies Mouridsen HT, et al.  Annals of Oncology 2007; 18:546-550.
 

PRESENTATIONS

Presentations ESMO 2006
Maike de Wit, MD - Department of Oncology and Haematology at the University of Hamburg Germany.  Successful treatment of anthracycline extravasation with Savene™ (dexrazoxane). Results from two multicenter prospective clinical studies.

Giuseppe Giaccone, Professor - Department of Medical Oncology At the Free University Medical Center, Amsterdam, The Netherlands Answers for Cancer (3.5Mb).

Peter Buhl Jensen, MD - CEO, TopoTarget Chromatin-Modulating Drugs: New mechanism-based therapeutics for cancer.

Nick La Thangue, Professor - Cancer Biology at the University of Oxford, Chief Business Development Officer, TopoTarget.

(Back to Top)

Home  |  Contact  | Disclaimer | Sitemap

TopoTarget USA :: 100 Enterprise Drive :: Rockaway, NJ 07866